Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | CHM-1101 |
Synonyms | |
Therapy Description |
Limited information is currently available on CHM-1101, a putative chlorotoxin-containing chimeric antigen receptor T-cell therapy (Apr 2023). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
CHM-1101 | CHM 1101|CHM1101 | Limited information is currently available on CHM-1101, a putative chlorotoxin-containing chimeric antigen receptor T-cell therapy (Apr 2023). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05627323 | Phase I | CHM-1101 | A Phase 1 Study to Evaluate CHM-1101 CAR T Cells in Patients With MMP2+ Recurrent or Progressive Glioblastoma | Recruiting | USA | 0 |